Role of nemonoxacin as a therapeutic option for community-acquired pneumonia in the era of atypical pathogens
Precision Medication · 2026-03 · 3 (1) · 100082
DOI: 10.1016/j.prmedi.2026.100082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Precision Medication, 2026-03. Verfasst von Xiaoping Zhang und 6 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhang, X., Mo, G., Zhu, F., Zhang, K., Tian, L., Lv, Y., & Chen, J. (2026). Role of nemonoxacin as a therapeutic option for community-acquired pneumonia in the era of atypical pathogens. Precision Medication, 3(1), 100082. https://doi.org/10.1016/j.prmedi.2026.100082
Vancouver
Zhang X, Mo G, Zhu F, Zhang K, Tian L, Lv Y, et al. Role of nemonoxacin as a therapeutic option for community-acquired pneumonia in the era of atypical pathogens. Precision Medication. 2026;3(1):100082. doi:10.1016/j.prmedi.2026.100082
BibTeX
@article{Zhang2026,
author = {Zhang, Xiaoping and Mo, Guoli and Zhu, Fengjia and Zhang, Kaiwen and Tian, Lijie and Lv, Yueran and Chen, Jing},
title = {Role of nemonoxacin as a therapeutic option for community-acquired pneumonia in the era of atypical pathogens},
journal = {Precision Medication},
year = {2026},
volume = {3},
number = {1},
pages = {100082},
doi = {10.1016/j.prmedi.2026.100082}
}
EUVIMED